HOME >> BIOLOGY >> NEWS
University of Pittsburgh named cooperative research center for muscular dystrophy

PITTSBURGH, Oct. 14 The University of Pittsburgh School of Medicine is among three medical schools nationwide to be named as a cooperative center for muscular dystrophy research by the National Institutes of Health (NIH).

The centers, also at the University of Washington, Seattle and the University of Rochester School of Medicine, New York, are each being funded for five years at up to $1 million a year. The Muscular Dystrophy Association is expected to issue an announcement of available supplements to provide up to $500,000 a year for three years at each center for additional projects.

A group of some 20 congenital muscle-wasting illnesses, muscular dystrophies are caused by genetic errors in a number of muscle genes. For example, the absence of a key muscle protein called dystrophin is the reason for Duchenne muscular dystrophy (DMD), the most common, debilitating and lethal childhood muscle disease, which affects about one in every 3,000 boys, according to the advocacy group Parent Project Muscular Dystrophy.

"We will develop strategies to treat these terrible diseases that threaten children's lives and make their lives miserable," said Joseph C. Glorioso III, Ph.D., chairman of the department of molecular genetics and biochemistry and director of the Molecular Medicine Institute at the University of Pittsburgh School of Medicine, principal investigator and director of the Pittsburgh center. "We also are working to find out more about the biology of these diseases."

Specific projects undertaken by scientists at the University of Pittsburgh involve preclinical and clinical studies of gene and stem cell therapies to treat muscle diseases DMD in particular.

Gene therapy will be the focus of two Pittsburgh projects. Scientists led by Xiao Xiao, Ph.D., associate professor of molecular genetics and biochemistry, will be working in collaboration with University of Missouri and Ohio State University scientists on preclinical a
'"/>

Contact: Michele Baum
baummd@upmc.edu
412-647-3555
University of Pittsburgh Medical Center
14-Oct-2003


Page: 1 2 3

Related biology news :

1. Indiana University, EPA to study airborne PCBs
2. University of Alberta researcher looks for clues to mysterious disease
3. Northeastern University receives $12.4 million NSF grant for creation of nanomanufacturing institute
4. Washington University in St. Louis leads group studying aging process
5. Tufts University establishes $4 million dollar tissue engineering resource center
6. Case for IBD combination therapy comes from research at Baylor, MIT and Hebrew University
7. As informatics grows, Indiana University helps set research agenda
8. University of Arizona licenses patent for natural fungicide
9. Washington University in St. Louis plays key role in sequencing moss genome
10. University of Pittsburgh receives $10 million grant for head and neck cancer
11. Clemson University spin-off uses corn to make plastics, provide cleaner air

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/18/2020)... (PRWEB) , ... July 17, 2020 , ... Commercial launch ... on pharma’s ability to discover a COVID cure or vaccine, the global economic downturn ... and price pressure is not going away and capturing full value from every product ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... solutions for biopharmaceutical R&D, today announced that it has entered into a ... multispecific antibodies (Multiclonics®), to support their translational and clinical research strategy to ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... Mass. and SOMERSET, N.J (PRWEB) , ... July ... ... leading genome editing company, and Catalent, the leading global provider of advanced delivery ... consumer health products, today announced that they have entered into a strategic partnership ...
(Date:7/22/2020)... ... , ... Join experts from Reed Tech , Gary Saner, Sr. Manager, ... hour live webinar on Thursday, August 13, 2020 at 11am EDT (4pm ... devices. Specifically, for medical devices, the NMPA has departments dealing with medical device registration ...
(Date:7/18/2020)... ... , ... dicentra , a leading Contract Research Organization ... pleased to announce that Charles Galea has joined its clinical trials division as ... accomplished and results-driven sales executive with over 10 years of expertise in business ...
(Date:7/10/2020)... ... July 09, 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage ... Allen R. Nissenson, M.D., F.A.C.P., as its Chief Medical Officer. Dr. Nissenson ... product, SBI-101. Dr. Nissenson serves as an Emeritus Professor of Medicine at ...
Breaking Biology Technology:
Cached News: